Back to BNP PARIBAS FINANCIAL MARKETS BNP PARIBAS FINANCIAL MARKETS

NKTRNKTR
5 quarters

Position history for BNP PARIBAS FINANCIAL MARKETSBNP PARIBAS FINANCIAL MARKETS's holdings in NEKTAR THERAPEUTICS

Yes. BNP Paribas Financial Markets holds 19,200 shares of NKTR (Nektar Therapeutics), worth $1.3M, as of its Q2 2026 13F filing. It reduced the position by 102,339 shares (-84.2%) from Q1 2026. BNP Paribas Financial Markets has held NKTR in every 13F on record since Q2 2025, 5 quarterly filings.

Current Value

$1.3M

Current Shares

19,200

Total Value Change

+$1.3M

Total Shares Change

+18,976

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
19,200
-84.2%
$1.3M0.0%$69.81
0
2026-Q1
Decreased
121,539
-42.2%
$8.7M0.0%$71.95
0
2025-Q4
Increased
210,298
+484x
$8.9M0.0%$42.28
44
2025-Q3
Increased
434
+93.8%
$24,6950.0%$56.90
21
2025-Q2
New
224
-
$5,7880.0%$25.84
24

Other major holders of NKTR: FMR LLC, BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used